Skip to content
Operation Infinite Justice – Lifestyle
Author:
BioLargo, Inc
BioLargo’s Subsidiary Clyra Medical Adds Third Distribution Channel Accelerating Commercial Rollout of ViaClyr Wound Irrigation Solution
September 3, 2026
BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026
September 1, 2026
BioLargo Reports Second Quarter 2026 Results; Revenue Up 12% Sequentially, Gross Margin Expands to 54%
August 17, 2026
BioLargo’s Lake Stockholm AEC Installation passes six months of PFAS remediation Topping Two Million Gallons
August 3, 2026
BioLargo Joins New Jersey Institute of Technology-Led PFAS Consortium; President Tonya Chandler Appointed to Board of Directors
July 30, 2026
BioLargo Equipment Solutions & Technologies’ “PFAS Lady” to Teach PFAS 101 at 41st Annual Tri-State Seminar
July 29, 2026
BioLargo PFAS Treatment Technology Featured in The Disruptive Quarterly
July 27, 2026
BioLargo Relaunching CupriDyne(R)-Based Consumer Products – Back by Popular Demand and Generated More than $125 Million in Pet-Care Sales
July 13, 2026
BioLargo Engineering Unit Awarded $1.4 Million in U.S. Air Force Environmental Contract Renewals
July 1, 2026
BioLargo Subsidiary Clyra Medical Signs Exclusive Distribution Agreement with Al- Hikma FZCO for ViaCLYR(TM) Across the Middle East, North Africa, and Adjacent Markets
May 5, 2026
1
2
Next Page
→